CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth

BACKGROUND: Loss of CD9 expression has been correlated with a higher motility and metastatic potential of tumour cells originating from different organs. However, the mechanism underlying this loss is not yet understood. METHODS: We produced a truncated form of partner 1 of CD9 (CD9P-1), GS-168AT2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilmain, W, Colin, S, Legrand, E, Vannier, J P, Steverlynck, C, Bongaerts, M, Vasse, M, Al-Mahmood, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049554/
https://www.ncbi.nlm.nih.gov/pubmed/21206492
http://dx.doi.org/10.1038/sj.bjc.6606033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049554/
https://www.ncbi.nlm.nih.gov/pubmed/21206492
http://dx.doi.org/10.1038/sj.bjc.6606033

Ejemplares similares